For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...

The board of Spanish plasma-based medicines producer Grifols has announced the termination of discussions with Brookfield ...

The embattled Spanish drugmaker Grifols SA is in talks with banks to refinance bonds due next year and extend a revolving ...

Grifols shares fell as much as 14 per cent after the news was published by Bloomberg, the biggest intra-day decline since Feb ...

Canadian investment fund Brookfield said Wednesday it has dropped its bid for Spanish pharmaceutical firm Grifols following ...

Barcelona-based Grifols has seen its stock value plummet since January when short seller Gotham City Research accused the company of manipulating debt and earnings reporting by consolidating profit ...

The Board of Directors of Grifols (GRFS) announced the termination of discussions with Brookfield Capital Partners UK regarding a ...

Grifols SA needs to focus on financial restructuring and address corporate governance issues to win over investors after ...

Plus, Brookfield drops deal for Spanish healthcare group Grifols and Sequoia Capital’s spun-off China unit hunts for global deals ...

Fortress is offering 310p per share, valuing the total equity of the company at around £338 million ($428 million; €406 ...

Expect thin trading on U.S. Thanksgiving holiday: The Toronto Stock Exchange will be front and centre today, as the ...